Published • loading... • Updated
After MFN Conflict: Amgen Gets New Contract for Repatha to Denmark
Summary by Dagens Medicin
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Amgen will once again supply the cholesterol drug Repatha to Denmark after the high-profile conflict when the company terminated the contract. Now Danish health economists believe that more companies could try the same thing, writes the news service Läkemedelsmarknaden.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
